期刊文献+

自然周期IVF/IVM、IVM和常规促排卵技术在不孕症治疗中的临床应用比较 被引量:2

Comparison of clinical outcomes for infertility treatment with natural cycle IVF/IVM,IVM and controlled ovarian hyperstimulation
原文传递
导出
摘要 目的探讨自然周期IVF结合未成熟卵母细胞IVM(自然周期IVF/IVM)和IVM技术与控制性促排卵技术(COH)相比,在不孕症治疗中的临床价值。方法根据筛查标准,将患者治疗方案分为以下3种类型:(A)自然周期IVF/IVM;(B)IVM;(C)COH。结果在1686个移植周期中,31.3%的周期(528个)应用自然周期IVF/IVM技术,12.8%实施IVM技术,55.9%通过COH方案治疗。自然周期IVF/IVM、IVM和COH的临床妊娠率分别为33.9%、39.8%和31.1%,IVM组高于其他两组但各组之间无显著差异,胚胎着床率也无显著差异。而IVM组的流产率(36.0%)高于其他两组(31.3%和25.9%),无显著统计学差异。结论从本研究可以看出,自然周期IVF/IVM和IVM方案可以解决近一半周期的不孕症患者,并且可以获得与COH相近的临床妊娠率。 Objective: To determine the clinical outcomes of natural cycle in vitro fertilization (IVF) combined with in vitro maturation (IVM) treatment (natural cycle IVF/IVM) , IVM alone compared with traditional controlled ovarian hyperstimulation (COH) on infertility treatment. Methods: Women with infertility according to ovarian reserve and endocrine profile were selected for different treatments. According to screening criteria, infertile women were divided into three treatments: (A) natural cycle IVF combined with IVM (IVF/IVM) ; (B) IVM alone; and (C) COH with gonadotropin. Results: A total of 1762 cycles were started, and 1686 cycles (95. 7%) were completed. Of 1686 cycles, 528 (31.3%) were treated by natural cycle IVFflVM, 216 (12. 8%) were conducted for IVM alone, and 942 (55.9%) underwent COH. The rates for IVM, fertilization and cleavage as well as clinical pregnancy and implantation were compared. Clinical pregnancy rates were 33.9% (179/528) for natural cycle IVF/IVM, 39.8% (86/216) for IVM alone, and 31.1% (293/942) for COIl with no significant differences among three groups as well as for implantation rate. Conclusion: Natural cycle IVF/IVM together with IVM-alone treatment can offer about half (44. 1%) of infertile women with an acceptable pregnancy and implantations rates.
出处 《中国优生与遗传杂志》 2014年第7期126-128,共3页 Chinese Journal of Birth Health & Heredity
关键词 自然周期 IVF IVM 促排卵 临床妊娠率 Natural cycle 1VF IVM COH Clinical pregnancyrate
  • 相关文献

参考文献15

  • 1Pinborg A, Loft A, Schmidt L, Andersen AN.Morbidity in a Danish national cohort of 472 IVF/ICSI twins, 1132 non-IVF/ICSI twins and 634 IVF/ICSI singletons :health related and social implicationsfor the children and their families[J].Hum Reprod, 2003, 18 (6) : 1234-43.
  • 2Vlahos NF, Gregoriou O.Prevention and management of ovarian hyperstimulation syndrome[J].Ann N Y Acad Sci, 2006, 1092 : 247-64.
  • 3Xu Y, Li J, Zhou G, Guo J.Clinical outcomes for various causes of infertility with natural cycle in vitro fertilization combined with in witro maturation of immature oocytes[J].Fertil Steril, 2010,94 ( 2 ) : 777-80.
  • 4Devigne A, Rozenberg S.Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS) :a review[J].Hum Reprod Update,2002,8 (6) :559-577.
  • 5Nikolaou D, Lavery S, Turner C, et al.Is there a link between an extremely poor response to ovarian hyperstimulation and early ovarian failure?[J].Hum Reprod, 2002, 17 (4) :1106-1111.
  • 6Althuis MD, Moghissi KS, Westhoff CL, et al.Uterine cancer after the use of clomiphene citrate to induce ovulation[J].Am J Epidemiol,2005, 161 (7) :607-615.
  • 7Janssens RM, Lambalk CB, Vermeiden JP, et al.In-vitro fertilization in a spontaneous cycle :easy, cheap and realistic[J]. Hum Reprod, 2000, 15:314-8.
  • 8Li J, Xu Y, Zhou G, et al.Natural cycle IVF/IVM may be more desirable for poor responder patients after failure of stimulated cycles[J].J Assist Reprod Genet, 2011,28 ( 9 ) : 791-795.
  • 9Schimberni M, Morgia F, Colabianchi J, et al.Natural-cycle in vitro fertilization in poor responder patients :a survey of 500 consecutive cycles[J].Fertil Steril, 2009,92 (4) : 1297-1301.
  • 10Papaleo E, De Santis L, Fusi F, et al.Natural cycle as first approach in aged patients with elevated follicle-stimulating hormone undergoing intracytoplasmic sperm injection :a pilot study[J].Gynecol Endocrinol, 2006, 22 (7) :351-354.

二级参考文献14

  • 1潘长穿,陈文卫,石华,孙有刚,杨菁,徐望明.阴道彩超预测基础FSH水平正常患者超排卵中卵巢反应性的价值[J].中国现代医学杂志,2005,15(9):1379-1382. 被引量:13
  • 2赵旭,刘平,刘鹏博(编校).控制超排卵中的卵巢低反应[J].中国妇幼保健,2006,21(8):1150-1153. 被引量:12
  • 3朱小明,蔡婕,黄荷凤.卵巢低反应的诊断标准和预测[J].中国实用妇科与产科杂志,2006,22(5):388-390. 被引量:50
  • 4Faddy M J, Gosden RG, Gougen A, et al. Accelerated disappearance of ovarine follicles in mid-life : implication for forescasting menophause[ J]. Hum Reprod, 1992, 7 (10) : 1342-1346.
  • 5Zhen XM, Qiao J, Li R, et al. The clinical analysis of poor ovarian response in in-vitro-fertilization embryo-transfer among Chinese couples[ J]. J Assist Reprod Genet, 2008, 25 (1) :17-22.
  • 6Detti L, Williams DB, Robins JC, et al. A comparison of three downregulation approaches for poor responders undergoing in vitro fertilization[J]. Fertil Steril, 2005, 84(5) : 1401-1405.
  • 7Akman MA, Erden HF, Tosun SB, et al. Addition of GnRH antagonist in cycles of poor responders undergoing IVF [ J ]. Hum Reprod, 2000, 15(10) : 2145-2147.
  • 8Al-Inany H, Aboulghar M. GnRH antagonists assisted reproduction: a Cochrane review[J]. Hum Reprod, 2002, 17(4) : 874- 885.
  • 9Albano C, Felberbaum RE, Smitz J, et al. Ovarian stimulation with HMG : results of a prospective randomized phase Ⅲ European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRHa-gonist buserelin [J]. Hum Reprod, 2000, 15(3) : 526-531.
  • 10Borm G, Mannaerts B. Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormoneis effective, safe and convenient: results of a controlled, randomized, multieentre trial. The European Orgalutran Study Group [ J ]. Hum Reprod, 2000, 15 (7) :1490-1498.

共引文献14

同被引文献10

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部